Specialty Research and Innovation
-
Featured
Favipiravir to Treat COVID-19: Q&A with Boris Juelg, MD, PhD
Boris Juelg, MD, PhD, an attending physician in the Division of Infectious Diseases at Massachusetts General Hospital and an assistant professor at Harvard Medical School, explains what is currently known about the drug favipiravir and why he is excited about its potential to treat COVID-19 patients.
-
Featured
Mass General Launching Randomized, Controlled Trial of Tocilizumab for COVID-19
Tocilizumab, a monoclonal antibody that blocks IL-6 already approved in the U.S., might be effective against COVID-19, researchers from Massachusetts General Hospital believe.
-
Featured
Using Chloroquine to Treat COVID-19: Q&A with Raghu Chivukula, MD, PhD
Raghu Chivukula, MD, PhD, a physician-scientist in the Division of Pulmonary and Critical Care Medicine at Massachusetts General Hospital, explains what is currently known about chloroquine and its use to treat COVID-19 patients.
-
A Hybrid Model of In-person and Telemedicine Visits Facilitates Longitudinal Care Delivery
The COVID-19 pandemic has catalyzed widespread usage of telemedicine due to the unprecedented need for remote patient care. Ami Bhatt, MD, discusses operationalizing a hybrid virtual cardiovascular clinic with a traditional in-person clinic in one large academic teaching hospital.
-
Novel Anticoagulation Protocol to Decrease Hemofilter Clotting in COVID-19 Patients
In a pilot study, Massachusetts General Hospital researchers found that dosing systemic heparin according to anti–factor Xa levels resulted in improved hemofilter life in critically ill COVID-19 patients undergoing continuous venovenous hemofiltration.
-
What Physicians Should Know About COVID-19 Vaccine Allergy: Q&A with Kimberly Blumenthal, MD, MSc
In this Q&A, Kimberly Blumenthal, MD, MSc, explains what may cause an allergic reaction to the vaccine, what makes someone higher risk for an adverse event, and what doctors can do to help patients understand and manage the risk.
Research and Innovation contributors
-
Andrew T. Chan, MD, MPH
Professor of Medicine, Harvard Medical School, Director for Cancer Epidemiology, Mass General Cancer Center, Chief, Clinical and Translational Epidemiology Unit, Department of Medicine
Recent Article
Physical Activity Reduces Chronic Liver Disease Mortality Risk
-
Benjamin David Medoff, MD
Chief, Division of Pulmonary and Critical Care, Principal Investigator, Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital
Recent Article
Medical Grand Rounds: Pathogenesis and Management of Respiratory Failure in COVID-19: What We Know So Far
-
Boris D. Juelg, MD, PhD
Attending Physician, Division of Infectious Diseases, Massachusetts General Hospital, Assistant Professor, Harvard Medical School
Recent Article
Favipiravir to Treat COVID-19: Q&A with Boris Juelg, MD, PhD
-
Bryan Hayes, PharmD, DABAT, FAACT, FASHP
Assistant Professor of Emergency Medicine, Harvard Medical School, Senior Attending Pharmacist, Emergency Medicine and Toxicology, Massachusetts General Hospital
Recent Article
The Use of NSAIDs in COVID-19 Patients: Q&A with Bryan D. Hayes, PharmD -
Charles Corey Hardin, MD, PhD
Physician, Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Associate Professor of Medicine, Harvard Medical School, Physician Investigator, Pulmonary, Mass General Research Institute
Recent Article
Review: Evidence-Based Management of the Critically Ill Adult with COVID-19
-
David M. Dudzinski, MD
Intensive Care Cardiologist, Massachusetts General Hospital, Director, Cardiac Intensive Care Unit, Associate Editor, Case Records of the MGH
Recent Article
Review: Evidence-Based Management of the Critically Ill Adult with COVID-19
-
Elizabeth Louise Hohmann, MD
Staff Physician, Infectious Diseases Division, Massachusetts General Hospital, Chair and Physician Director, Partners Human Research Committees
Recent Article
Encapsulated Fecal Microbiota Transplantation Alters Gut Microbiome in Adults with Obesity -
Gregory D. Lewis, MD
Section Head, Heart Failure, Director, Cardiopulmonary Exercise Testing Laboratory, Medical Director, Cardiology ICU and Mechanical Circulatory Support Program
Recent Article
Feasibility of a Viral Filter for Cardiopulmonary Exercise Testing During the COVID-19 Pandemic
-
Guillermo (Gary) Tearney, MD, PhD
Professor of Pathology, Harvard Medical School, Pathologist/Physicist, Massachusetts General Hospital, Faculty, Wellman Center for Photomedicine
Recent Article
MGH Research Scholars Respond to COVID-19 -
Lorenzo Berra, MD
Medical Director, Respiratory Care, Massachusetts General Hospital
Recent Article
Case Series: Inhaled Nitric Oxide for Pregnant Patients with Severe or Critical COVID-19
-
Louise C. Ivers, MD
Executive Director of the Mass General Center for Global Health, Associate Physician in the Division of Infectious Diseases
Recent Article
Medical Grand Rounds: COVID-19 in Low-Resourced Settings—Reaching for Global Health Equity -
Raghu Chivukula, MD, PhD
Physician-Scientist, Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital
Recent Article
Review: Evidence-Based Management of the Critically Ill Adult with COVID-19
-
Tomas G. Neilan, MD, MPH
Director, Cardio-Oncology Program, Massachusetts General Hospital, Co-Director, Cardiac MR PET CT Program
Recent Article
Myocarditis from Immune Checkpoint Inhibitors Potentially Mitigated by Early Corticosteroid
-
Vicki Jackson, MD
Chief, Palliative Care, Massachusetts General Hospital
Recent Article
Pilot of Embedded Palliative Care Early in COVID-19 Was Well Received by Emergency Clinicians
